Repurposing butenafine as an oral nanomedicine for visceral leishmaniasis

  1. Bezerra-Souza, A.
  2. Fernandez-Garcia, R.
  3. Rodrigues, G.F.
  4. Bolas-Fernandez, F.
  5. Laurenti, M.D.
  6. Passero, L.F.
  7. Lalatsa, A.
  8. Serrano, D.R.
Journal:
Pharmaceutics

ISSN: 1999-4923

Year of publication: 2019

Volume: 11

Issue: 7

Type: Article

DOI: 10.3390/PHARMACEUTICS11070353 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus